Skip to main content
. 2019 Sep 30;23(3):263–275. doi: 10.12717/DR.2019.23.3.263

Table 2. Tissue specific localization of ESR1, ESR2 and PGR in mouse uterus that were treated with DEHP or NP. Quantification is presented by the number of + or −, negative.

μg/L ESR1 ESR2 PGR
St GE LE St GE LE St GE LE
Contl Nucleus +++ +++ +++ ++ ++ ++
Cytoplasm +++ +++ ++ +++ +++
DEHP 133 Nucleus +++ +++ +++ ++ ++ ++ +++ +++ +++
Cytoplasm +++ +++ +++ +++ +++ +++
DEHP 1330 Nucleus + + +
Cytoplasm +++ +++ +++ +++ +++ +++
NP 50 Nucleus +++ +++ +++ +++ +++
Cytoplasm +++ +++ +++ +++ +++ +++
NP 500 Nucleus +++ +++ +
Cytoplasm +++ +++ +++ +++ +++ +++

St, stroma; GE, glandular epithelium; LE, luminal epithelium; Cont, control.

ESR1, estrogen receptor 1; ESR2, estrogen receptor 2; PGR, progesterone receptor; DEHP, di(2 ethylhexyl) phthalate; NP, nonylphenol.